March 9, 2010
New Treatments for HIV: Part 2
by Tim Horn
At the 17th Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco—Tim Horn speaks with David Hardy, MD, from Cedars Sinai Medical Center in Los Angeles, about new HIV treatments—including two entry inhibitors: vicriviroc and TBR-652. Part 2 of a 2-part video.
Search: David Hardy, vicriviroc, Tobira, TBR-652, selzentry, entry inhibitor, CCR5, CCR2, inflammation
Scroll down to comment on this story.
[Go to top]